Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experience with International Neuroblastoma Staging System and Pathology Classification.

H Ikeda1, T Iehara, Y Tsuchida

  • 1Department of Pediatric Surgery, Dokkyo University School of Medicine, Koshigaya Hospital, 2-1-50 Minami-Koshigaya, Koshigaya, Saitama 343-8555, Japan.

British Journal of Cancer
|April 16, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Congenital urethrocutaneous fistula.

International journal of urology : official journal of the Japanese Urological Association·2000
Same author

Comparison of water- and land-based exercise in the reduction of state anxiety among older adults.

Perceptual and motor skills·2000
Same author

Developmental expression pattern of the cdo gene.

Developmental dynamics : an official publication of the American Association of Anatomists·2000
Same author

Laparoscopic esophagomyotomy with dor anterior fundoplication in a child with achalasia.

Surgical laparoscopy, endoscopy & percutaneous techniques·2000
Same author

Meconium peritonitis in utero.

Pediatric surgery international·2000
Same author

The expression of presenilin 1 mRNA in skin fibroblasts and brains from sporadic Alzheimer's disease.

Dementia and geriatric cognitive disorders·2000
This summary is machine-generated.

The International Neuroblastoma Staging System (INSS) and Pathology Classification are valuable tools for predicting neuroblastoma patient survival. These classifications, along with biological factors like MYCN amplification, significantly impact prognosis across different age groups.

Area of Science:

  • Pediatric Oncology
  • Cancer Staging and Classification
  • Neuroblastoma Research

Background:

  • The International Neuroblastoma Staging System (INSS) and International Neuroblastoma Pathology Classification (INPC) were established to standardize neuroblastoma diagnosis and prognosis.
  • However, their clinical utility and impact on survival outcomes in contemporary patient cohorts require further investigation.

Purpose of the Study:

  • To evaluate the clinical value of the INSS and INPC in predicting survival outcomes for neuroblastoma patients.
  • To assess the association of biological factors with prognosis in different age groups.

Main Methods:

  • Analysis of 644 neuroblastoma patients treated between 1995 and 1999.
  • Stratification of patients by age (<12 months and >=12 months).

Related Experiment Videos

  • Evaluation of survival rates based on INSS stages, INPC histology, and biological factors (MYCN amplification, DNA diploidy, 1p deletions).

    • Main Results:

    • Both INSS stage and INPC histology were significantly associated with 4-year overall survival in both age groups (P<0.0001).
    • Patients with INSS stage 4 or unfavorable histology had significantly lower survival rates.
    • MYCN amplification and DNA diploidy were identified as independent prognostic factors.

    Conclusions:

    • The INSS and INPC are crucial for predicting neuroblastoma patient survival, independent of other factors.
    • Age, INSS stage, and INPC histology are key determinants of treatment outcomes.
    • Biological markers like MYCN amplification further refine prognostic assessments.